Clinical Trial Update: Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Mycograb as adjunctive therapy for cryptococcal meningitis in AIDS patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis

Drugs mentioned

• Mycograb

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cryptococcal Meningitis | Phase 2 | Status: TERMINATED